Patient Tool References

 
  1. Abbott Laboratories, Limited. Product Monograph HUMIRA® (adalimumab). Submission Control No: 113975. Date of approval:  January 23, 2008
  2. Actavis Group PTC ehf. Product Monograph SORIATANE® (acitretin).  Submission Control No: 121988.  Date of preparation: May 16, 2008.
  3. The Arthritis Society of Canada, (Apr 2008). Psoriatic Arthritis. URL: http://www.arthritis.ca/types%20of%20arthritis/
  4. Astellas Pharma Canada, Inc.  Product Monograph AMEVIVE® (alefecept). Submission Control No: 105484.  Date of revision: June 1, 2006.
  5. Bhosle MJ, et al. Quality of life in patients with psoriasis. Health and Quality of Life Outcomes 2006;4:35 doi:10.1186/1477-7525-4-35.
  6. Bren Linda. Psoriasis: More than Cosmetic.  FDA Consumer Magazine (Sep-Oct 2004 Issue): www.fda.gov
  7. British Association of Dermatologists: www.bad.org.uk
  8. Canadian Dermatology Association:  www.dermatology.ca
  9. Canadian Diabetes Association Are You At Risk:  www.diabetes.ca
  10. Centocor, Inc.  Product Monograph REMICADE® (infliximab).  Submission Control No: 120814.  Date of approval: June 30, 2008
  11. Centocor Inc. Psoriatic Diseases:  www.psoriaticdiseases.com
  12. Chuh A, et al. The skin and the mind. Australian Family Physician 2006;35(8):723-5. www.racgp.org.au
  13. Elder JT et al. The Genetics of Psoriasis 2001: The Odyssey Continues. Arch Dermatol/Vol 137, Nov 2001
  14. Engel, J. The Complete Canadian Health Guide (revd ed) Toronto: 1999, Key Porter Books with the University of Toronto Faculty of Medicine.
  15. Finlay AY. Current severe psoriasis and the rule of tens. Br J Dermatol 2005;152(5):861-7.
  16. Fortes C, et al. Relationship between smoking and the clinical severity of psoriasis Arch Dermatol 2005;141:1580-84.
  17. Gelfand JM, et al. Risk of myocardial infarction in patients with psoriasis. JAMA 2006;296(14):1735-41.
  18. Gladman DD et al. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis 2005;64(Suppl II):ii14=ii17
  19. Goodless Dean, M.D. (juill. 2008). Risks of Depression in Psoriasis:  psoriasis.about.com/od/relatedconditions/a/depression.htm
  20. Health Canada Mental Heatlh – Coping with Stress. It’s Your Health:  www.hc-sc.gc.ca/iyh-vsv/life-vie/stress_e.html
  21. Herron MD, et al. Impact of obesity and smoking on psoriasis presentation and management. Arch Dermatol 2005;141:1527-34.
  22. Horn EJ, et al. Are patients with psoriasis under treated? Results of National Psoriasis Foundation survey. J Am Acad Dermatol 2007;57:957-62.
  23. Huerta C, et al. Incidence and risk factors for psoriasis in the general population. Arch Dermatol 2007;143(12):1559-65.
  24. Immunex Corporation.  Product Monograph ENBRELl® (etanercept). Submission Control No: 11804.  Date of approval: January 15, 2008
  25. Janssen-Ortho Inc. Product Monograph STELARA®.  Submission Control No: 114272. Date of approval: December 12, 2008
  26. Krueger G, et al. The Impact of Psoriasis on Quality of Life. Results of a 1998 National Psoriasis Foundation Patient-Membership Survey. Arch Dermatol 2001;137:280-4.
  27. McGill University, Department of Psychology, (2004). Background theory from academic research on self-esteem.  Resources.  Self-Esteem Games: selfesteemgames.mcgill.ca/resources/index.htm
  28. Mexdus Inc. Product Monograph Methoject. Control Number: 107035. Date of preparation January 08, 2008
  29. Mrowietz U, et al. The importance of disease associations and concomitant therapy for the long-term management of psoriasis patients. Arch Dermatol Res 2006;298:309-19.
  30. Nall, L., Gulliver, W., Charmley, P. and Farber, E.M. (1999) Search for the psoriasis susceptibility gene: the Newfoundland Study. Cutis, 64, 323–329.[ISI][Medline] as reported in Feldman Steven, What’s New in Psoriasis: www.medscape.com
  31. National Psoriasis Foundation : www.psoriasis.org
  32. Novartis Pharmaceuticals Canada Inc. Product Monograph NEORAL® and SANDIMMUNE I.V.® Submission Control No: 115724.  Date of revision October 29, 2007.
  33. Peel Public Health, (Jul 2007).  Adapted from Self Esteem: The Process of Strengthening Self-Esteem: www.region.peel.on.ca/health/commhlth/selfest/process.htm
  34. Ramsay B et al. A survey of the social and psychological effects of psoriasis Br J Dermatol 1988;118:195-201.  As reported in Psoriasis: More Than Skin Deep Brochure of The Psoriasis Association (www.psoriasis-association.org.uk )
  35. Reich A, et al. Does stress influence itching in psoriatic patients? Dermatol and Psychosomatics 2003;4:151-5.
  36. Smith CH, Barker NWN. Psoriasis and its management. BMJ 2006;333:380-4
  37. Smith M. Do smoking and drinking affect psoriasis? www.dermaharmony.com/library/alcoholtobaccopsoriasis.asp

Submitted by site_admin on Mon, 04/05/2010 - 12:01

Severity Calculator download available at the app store


  • Psoriasis Treatment Options
  • Dermatologist Talk
  • Psoriasis Severity Calculator
  • Psoriasis Questionnaire